BioAtla, Inc. — Director's Dealing 2021

Nov 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2021-11-02

Reporting Person: STEINMAN LAWRENCE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-02	Common Stock	S	450	$30.00	Disposed	18459	Direct

Footnotes

F1: Sale effected under sales plan pursuant to Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended.